Quarterly report pursuant to Section 13 or 15(d)

Supplemental Disclosure of Cash Flow Information (Tables)

v3.10.0.1
Supplemental Disclosure of Cash Flow Information (Tables)
9 Months Ended
Sep. 30, 2018
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Cash Flow Information

The supplemental cash flow information for the nine months ended September 30, 2018 and 2017 (unaudited) is as follows:

 

    Nine Months Ended September 30,  
    2018     2017  
Cash paid for interest   $ 302,308     $ 1,106,835  
Cash paid for income taxes   $ 20,000     $ 506,313  
                 
Acquisition of Jamestown Regional Medical Center:                
Cash   $ -     $ -  
Inventory   $ 450,682     $ -  
Prepaid expenses and other current assets   $ 310,385     $ -  
Property and equipment   $ 7,347,468     $ -  
Intangible assets   $ 486,716     $ -  
Accrued expenses   $ (193,966 )   $ -  
                 
Non-cash investing and financing activities:                
Exchange of preferred stock for convertible debentures and warrants   $ -     $ 10,734,336  
Cashless exercise of warrants   $ 4,619,150     $ -  
Exchange of convertible debentures for convertible debentures and warrants   $ -     $ -  
Exchange of debentures for Series I-2 Preferred Stock   $ 1,420     $ -  
Services and severance settled through issuance of common stock   $ -     $ 161,003  
Note payable, warrants, and accrued expenses settled through issuance of common stock   $ -     $ 440,000  
Note payable and accrued expenses settled through issuance of Series J Preferred Stock   $ 250,000       -  
Exchange of Series H Preferred Stock for debentures   $ -     $ 2,695,760  
Series F Preferred Stock issued for business acquisition   $ -     $ 174,097  
Debentures converted into common stock   $ 8,085,342     $ 4,064,162  
OID from issuance of debentures   $ 1,920,000     $ -  
Conversions of shares of Preferred Stock into common stock   $ 633,100     $ -  
Conversions of shares of Series H Preferred Stock into common stock   $ 50,000     $ -  
Deemed dividend for trigger of down round provision feature   $ 17,942,578     $ 53,341,619